NanoEcho has today published the report for the second quarter! Watch as CEO Linda Persson summarises the quarter, during which we have not only completed product development and passed the formal verification, but also successfully certified our quality management system according to ISO 13485 and conducted a health economic analysis with promising results.
“During this quarter, our team has delivered an outstanding performance, and we have now successfully transitioned from the research laboratory at Lund University to having a commercial imaging system ready for clinical studies. With product development completed, we are making a clear strategic shift and are now fully focused on the clinical phase – a phase for which we are well prepared,” commented CEO Linda Persson.
The full report is available in Swedish here!
